Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources
KFF Health Tracking Poll – October 2019: Health Care In The Democratic Debates, Congress, And The Courts
This poll examines health care issues in the Democratic presidential primary , government negotiation of prescription drug prices, party trust on health care, Medicare-for-all, and the pending Texas v. US lawsuit affecting the Affordable Care Act and pre-existing condition protections.
Poll Finding See More
Related Prescription Drugs Resources
- 10 FAQs on Prescription Drug Importation
- Pricing and Payment for Medicaid Prescription Drugs
- Management and Delivery of the Medicaid Pharmacy Benefit
- Understanding the Medicaid Prescription Drug Rebate Program
- A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
- Kaiser Health News Coverage of Prescription Drug Issues
- What are the recent and forecasted trends in prescription drug spending?
- What’s the Latest on Medicare Drug Price Negotiations?
- How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
- Medicaid’s Prescription Drug Benefit: Key Facts
- Public Opinion on Prescription Drugs and Their Prices
- Prescription Drug Rebates, Explained
- What Are Recent Trends and Characteristics of Workers with High Drug Spending?
- Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control
- 10 Essential Facts About Medicare and Prescription Drug Spending
- Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs
- How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
This quick primer explains the similarities and differences among major proposals to lower prescription drug costs introduced by House Democrats, the Senate Finance Committee, and the Trump Administration as of December 2019.
Slideshow See More
- view as grid
- view as list
This chartbook provides information on key trends in the health care marketplace including health spending, the structure of the health care marketplace, and health plan and provider relationships. It highlights data on health plan enrollment, premiums, and benefits, and the implications of health market trends for consumers and the safety…Report Read More
This policy brief describes the financing of Illinois' new Medicaid prescription drug waiver. Policy Brief Also see The New Medicaid and CHIP Waiver InitiativesIssue Brief Read More
This issue brief, prepared as part of the National ADAP Monitoring Project, examines how ADAPs purchase and dispense drugs, and the drug discount programs that assist states in containing ADAP costs. For more information on the series see the National ADAP Monitoring Project page. Issue BriefIssue Brief Read More
Testimony by Patricia Neuman, Sc.D., vice president and director of the Foundation’s Medicare Policy Project, for the House Committee on Energy and Commerce, Subcommittee on Health, hearing on Creating a Medicare Prescription Drug Benefit: begins with a brief review of existing sources of prescription drug coverage for the Medicare population…Event Read More
2001 Retiree Health and Prescription Drug Coverage SurveyThis survey, released by the Kaiser Family Foundation, The Commonwealth Fund, and HRET, profiles retiree health coverage for Medicare-age (65+) retirees, including the amount retirees pay for coverage compared to active workers, cost-sharing for prescription drugs, and eligibility requirements for retiree benefits. The…Report Read More
Health News Index March/April, 2002 The March/April edition of the Kaiser Family Foundation/Harvard School of Public Health Health News Index includes questions about major health stories covered in the news, including the recent coverage of mammogram efficacy, the Institute of Medicine report on racial disparities in the health care system,…Poll Finding Read More
This report, the sixth in an annual series, provides an overview of the status of state-administered AIDS Drug Assistance Programs (ADAPs) and documents how these programs are responding to the changing fiscal, clinical and epidemiological dynamics of HIV/AIDS. ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources…Report Read More
This study examines Medicaid pharmacy benefit use and spending among beneficiaries dually eligible for Medicare and Medicaid in 10 states by analyzing 1995 enrollment and claims data from a new 12-state database. The study finds that dual-eligibles are relatively high users of the Medicaid pharmacy benefit, with substantial variation in…Report Read More
This testimony was delivered by Tricia Neuman, a vice president of the Kaiser Family Foundation, at a Senate Finance Committee hearing on the Bush Administration's Proposals for Medicare Modernization. The statement, which draws upon a report prepared for the Foundation by Health Policy Alternatives, Inc., provides an overview of existing…Report Read More
The President's Fiscal Year 2003 Budget: An Overview of Health ProgramsA new chartbook describes the government's overall budget situation and examines the health policies and programs proposed in the President's latest budget.Chartbook View a webcast of A Capitol Hill briefing on budgets and health careReport Read More